OPTN
Price
$6.38
Change
+$0.35 (+5.80%)
Updated
Jan 17 closing price
Capitalization
164.47M
47 days until earnings call
TXMD
Price
$1.06
Change
+$0.02 (+1.92%)
Updated
Jan 17 closing price
Capitalization
24.32M
33 days until earnings call
Ad is loading...

OPTN vs TXMD

Header iconOPTN vs TXMD Comparison
Open Charts OPTN vs TXMDBanner chart's image
OptiNose
Price$6.38
Change+$0.35 (+5.80%)
Volume$109.79K
Capitalization164.47M
TherapeuticsMD
Price$1.06
Change+$0.02 (+1.92%)
Volume$60.57K
Capitalization24.32M
OPTN vs TXMD Comparison Chart
Loading...
OPTN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TXMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OPTN vs. TXMD commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OPTN is a Hold and TXMD is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 18, 2025
Stock price -- (OPTN: $6.38 vs. TXMD: $1.06)
Brand notoriety: OPTN and TXMD are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: OPTN: 139% vs. TXMD: 15%
Market capitalization -- OPTN: $164.47M vs. TXMD: $24.32M
OPTN [@Pharmaceuticals: Other] is valued at $164.47M. TXMD’s [@Pharmaceuticals: Other] market capitalization is $24.32M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.54B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OPTN’s FA Score shows that 0 FA rating(s) are green whileTXMD’s FA Score has 0 green FA rating(s).

  • OPTN’s FA Score: 0 green, 5 red.
  • TXMD’s FA Score: 0 green, 5 red.
According to our system of comparison, both OPTN and TXMD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OPTN’s TA Score shows that 4 TA indicator(s) are bullish while TXMD’s TA Score has 2 bullish TA indicator(s).

  • OPTN’s TA Score: 4 bullish, 4 bearish.
  • TXMD’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, OPTN is a better buy in the short-term than TXMD.

Price Growth

OPTN (@Pharmaceuticals: Other) experienced а +20.49% price change this week, while TXMD (@Pharmaceuticals: Other) price change was -3.64% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.23%. For the same industry, the average monthly price growth was +2.88%, and the average quarterly price growth was -9.56%.

Reported Earning Dates

OPTN is expected to report earnings on Mar 06, 2025.

TXMD is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.23% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OPTN($164M) has a higher market cap than TXMD($24.3M). TXMD YTD gains are higher at: 23.256 vs. OPTN (-4.491). TXMD has higher annual earnings (EBITDA): 52.6M vs. OPTN (-15.55M). OPTN has more cash in the bank: 73.7M vs. TXMD (10.2M). TXMD has less debt than OPTN: TXMD (8.2M) vs OPTN (132M). OPTN (71M) and TXMD (69.4M) have equivalent revenues.
OPTNTXMDOPTN / TXMD
Capitalization164M24.3M675%
EBITDA-15.55M52.6M-30%
Gain YTD-4.49123.256-19%
P/E RatioN/A0.47-
Revenue71M69.4M102%
Total Cash73.7M10.2M723%
Total Debt132M8.2M1,609%
FUNDAMENTALS RATINGS
OPTN vs TXMD: Fundamental Ratings
OPTN
TXMD
OUTLOOK RATING
1..100
6973
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
46
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10093
PRICE GROWTH RATING
1..100
9491
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
250

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OPTN's Valuation (38) in the Medical Or Nursing Services industry is in the same range as TXMD (46) in the Pharmaceuticals Generic industry. This means that OPTN’s stock grew similarly to TXMD’s over the last 12 months.

OPTN's Profit vs Risk Rating (100) in the Medical Or Nursing Services industry is in the same range as TXMD (100) in the Pharmaceuticals Generic industry. This means that OPTN’s stock grew similarly to TXMD’s over the last 12 months.

TXMD's SMR Rating (93) in the Pharmaceuticals Generic industry is in the same range as OPTN (100) in the Medical Or Nursing Services industry. This means that TXMD’s stock grew similarly to OPTN’s over the last 12 months.

TXMD's Price Growth Rating (91) in the Pharmaceuticals Generic industry is in the same range as OPTN (94) in the Medical Or Nursing Services industry. This means that TXMD’s stock grew similarly to OPTN’s over the last 12 months.

TXMD's P/E Growth Rating (100) in the Pharmaceuticals Generic industry is in the same range as OPTN (100) in the Medical Or Nursing Services industry. This means that TXMD’s stock grew similarly to OPTN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OPTNTXMD
RSI
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 5 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
89%
Bullish Trend 5 days ago
67%
Momentum
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
84%
MACD
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 5 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 5 days ago
85%
Advances
ODDS (%)
Bullish Trend 17 days ago
79%
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 5 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
89%
Bearish Trend 5 days ago
88%
Aroon
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
84%
View a ticker or compare two or three
Ad is loading...
OPTN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TXMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

OPTN and

Correlation & Price change

A.I.dvisor tells us that OPTN and PROC have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OPTN and PROC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OPTN
1D Price
Change %
OPTN100%
+5.80%
PROC - OPTN
28%
Poorly correlated
-2.29%
RMTI - OPTN
25%
Poorly correlated
+0.95%
TXMD - OPTN
21%
Poorly correlated
+1.92%
INDV - OPTN
21%
Poorly correlated
-0.09%
AQST - OPTN
21%
Poorly correlated
+0.32%
More

TXMD and

Correlation & Price change

A.I.dvisor tells us that TXMD and SCYX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TXMD and SCYX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TXMD
1D Price
Change %
TXMD100%
+1.92%
SCYX - TXMD
30%
Poorly correlated
-1.75%
ASRT - TXMD
27%
Poorly correlated
+2.83%
RMTI - TXMD
22%
Poorly correlated
+0.95%
OPTN - TXMD
21%
Poorly correlated
+5.80%
CTLT - TXMD
21%
Poorly correlated
N/A
More